Outcomes In Zuma-5 With Axicabtagene Ciloleucel In Patients With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma Who Had The High-Risk Feature Of Early Progression After First Chemoimmunotherapy
Axicabtagene Ciloleucel
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Outcomes In Zuma-5 With Axicabtagene Ciloleucel In Patients With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma Who Had The High-Risk Feature Of Early Progression After First Chemoimmunotherapy ### Output: Axicabtagene Ciloleucel